Fat Mass- and Obesity-Associated (FTO) Gene and Antipsychotic-Induced Weight Gain: An Association Study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuropsychobiology

• Publication date

  2014-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000356231PMID 24481458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.

  2012cited by this paper
• Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

  2012cited by this paper
• Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome

  2012cited by this paper
• Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene

  2012cited by this paper
• Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications

  2012cited by this paper
• Functional coupling analysis suggests link between the obesity gene FTO and the BDNF-NTRK2 signaling pathway

  2011cited by this paper
• Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study)

  2011cited by this paper
• Effect of FTO, SH2B1, LEP, and LEPR Polymorphisms on Weight Gain Associated With Antipsychotic Treatment

  2010cited by this paper
• Association Study of Energy Homeostasis Genes and Antipsychotic-Induced Weight Gain in Patients with Schizophrenia

  2010cited by this paper
• A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia

  2010cited by this paper
• Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity

  2009cited by this paper
• Combined effects of MC4R and FTO common genetic variants on obesity in European general populations

  2009cited by this paper
• Pharmacogenetics of antipsychotic-induced side effects

  2009cited by this paper
• Hypothalamic FTO is associated with the regulation of energy intake not feeding reward

  2009cited by this paper
• BDNF Levels and Genotype are Associated with Antipsychotic-Induced Weight Gain in Patients with Chronic Schizophrenia

  2008cited by this paper
• The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain.

  2008cited by this paper
• Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype Data

  2008cited by this paper
• A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity

  2007cited by this paper
• Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits

  2007cited by this paper
• Variation in FTO contributes to childhood obesity and severe adult obesity

  2007cited by this paper
• Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

  2007cited by this paper
• The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase

  2007cited by this paper
• QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies

  2006cited by this paper
• The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.

  2005cited by this paper
• Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia.

  2005cited by this paper
• Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

  2004cited by this paper
• Obesity as a risk factor for antipsychotic noncompliance.

  2004cited by this paper
• Contents of The American Journal of Psychiatry

  2004cited by this paper
• Pedigree disequilibrium tests for multilocus haplotypes

  2003cited by this paper
• 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.

  2002cited by this paper
• −759C/genetic variation of 5HT2C receptor and clozapine-induced weight gain

  2002cited by this paper
• Bodyweight Gain with Atypical Antipsychotic

  2001cited by this paper
• Antipsychotic-induced weight gain: a comprehensive research synthesis.

  1999cited by this paper
• A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

  1991cited by this paper

• Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients

  2021cites this paper
• Erasing m6A-dependent transcription signature of stress-sensitive genes triggers antidepressant actions

  2021cites this paper
• PGPM_A_327353 1123..1131

  2021cites this paper
• Genetic association between antipsychotic induced weight gain and FTO gene in a Sri Lankan population

  2019cites this paper
• Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population

  2019cites this paper
• Altering of FTO in the serum and livers of NAFLD patients : a correlation analysis

  2018cites this paper
• Fat Mass and Obesity-Related Gene Variants rs9939609 and rs7185735 are Associated with Second-Generation Antipsychotic-Induced Weight Gain

  2018cites this paper
• Identification of genetic basis of obesity and mechanistic link of genes and lipids in Pakistani population

  2018cites this paper
• The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment

  2018cites this paper
• Development of multivariable models to predict change in Body Mass Index within a clinical trial population of psychotic individuals

  2017cites this paper
• The p. N103K mutation of leptin (LEP) gene and severe early onset obesity in Pakistan

  2016cites this paper
• Lipids, Low-Grade Chronic Inflammation and NAFLD: A Ménage À Trois?

  2016cites this paper
• Lipids, Low-Grade Chronic Inflammation and NAFLD

  2016cites this paper
• Lipids Nutrition and Epigenetic Modification in Obesity-Related Co-Morbitities**All authors equally contributed to draft the manuscript. All authors gave final approval of the version to be published. Disclosure statement: The authors declare that there are no conflicts of interest

  2016cites this paper
• Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.

  2016cites this paper
• Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes

  2015cites this paper
• Genetic polymorphisms, DNA methylation and antipsychotic induced weight gain in schizophrenia patients.

  2015cites this paper
• Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update

  2015cites this paper
• Effect of the Common Fat Mass and Obesity Associated Gene Variants on Obesity in Pakistani Population: A Case-Control Study

  2015cites this paper
• Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed

  2014cites this paper
• Clozapine safety, 40 years later.

  2014cites this paper